Coherus BioSciences, Inc. (CHRS) is a late-stage clinical biologics platform company.
The company focuses on developing and commercializing biosimilar products worldwide.
The company's product candidates include CHS-1701, a pegfilgrastim biosimilar candidate, which is used for the treatment of febrile neutropenia; CHS-0214, an etanercept biosimilar candidate, which is in various phases of clinical trials for the treatment of ankylosing spondylitis, juvenile idiopathic arthritis, psoriatic arthritis, rheumatoid arthritis, and psoriasis; and CHS-5217, a bevacizumab biosimilar candidate, which is in preclinical stage for the treatment of metastatic colorectal cancer, non-small cell lung cancer, metastatic kidney cancer, advanced cervical cancer, platinum-resistant ovarian cancer, and recurrent glioblastoma.
Its product candidates also comprise CHS-1420, an adalimumab biosimilar candidate, which is in various phases of clinical trials to treat ankylosing spondylitis, Behçet's Disease, Crohns Disease, juvenile idiopathic arthritis, psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis; and CHS-3351, a ranibizumab biosimilar candidate, which is in preclinical stage for the treatment of neovascular (wet) age-related macular, degeneration, macular edema following retinal vein occlusion, diabetic macular edema, and diabetic retinopathy.
Coherus Biosciences, Inc. has license agreement with Daiichi Sankyo Company, Limited; Baxalta Incorporated, Baxalta US Inc., and Baxalta GmbH; Genentech, Inc.; and Selexis SA.
Shares have broken out of a bullish "flag" that shares had formed following its latest earnings report. Shares rose yesterday after the Patent Trial and Appeal Board ruled in favor of the company's petitions for Inter Partes Review of AbbVie's (ABBV) '135 Patent. Citi sees $4 to $8 per share upside for Coherus Biosciences following the ruling while Maxim raised its price target on Coherus shares to $44. Higher share prices are expected for this stock.
52-Weeks Trading Range: $14.00 - $31.98
Entry Point: $24.00
Stop Loss: $22.80
Target Price: $26.40
CHRS closed at $15.00
California Resources Corporation (CRC) operates as an oil and natural gas exploration and production company in the State of California.
It produces oil, natural gas, and natural gas liquids.
The company holds interests in approximately 2.4 million net acres. As of December 31, 2015, it had net proved reserves of 644 million barrels of oil equivalent. It also gathers, processes, and markets oil and gas products to marketers, California refineries, and other purchasers that have access to transportation and storage facilities.
It operates approximately three drilling rigs across the state with over two located in the San Joaquin basin (steamflood activities) and approximately one in the Los Angeles basin (waterflood activities). It has drilled over 290 gross development wells with over 250 wells in the San Joaquin basin and approximately 30 wells in the Los Angeles basin. It has also drilled approximately three exploration wells in the San Joaquin basin. Its operations include approximately 140 fields with over 9,070 gross active wellbores.
In addition, the company generates and sells electricity to the grid and to others through contractual agreements.
Shares are heading higher in an "upward trading channel" as shown in blue on the chart. They are currently at the lower boundary of the said channel. Please note that we recommended this stock at $22.00, we nw like it better at $19! The firm reports today after the close.
52-Weeks Trading Range: $2.81 - $25.50
Entry Point: $19.00
Stop Loss: $18.00
Target Price: $21.00
CRC closed at $15.20
Momo Inc. (MOMO) operates as a mobile-based social networking platform in the Peoples Republic of China.
The companys platform includes its Momo mobile application and various related features, functionalities, tools, and services that are provided to users, customers, and platform partners.
Its Momo mobile application enables users to establish and expand their social relationships based on locations and interests. The Momo mobile application, which is available on android, iPhone operating system (iOS) and Windows platforms, enables users to establish social relationships based on locations and interests. Momo offers a personal way for users to discover people nearby, and the Company facilitates the connecting, communicating, interacting, and content sharing with others.
The company also offers games, which are designed with various themes, cultural characteristics, and features to appeal to various segments of the game player community; paid emoticons and mobile marketing services; and live music and entertainment broadcasting services.
Shares are heading higher in an upward "trading channel." The formation is supported by the stock's 50-day moving average, shown in green. Higher share prices are expected from present levels! The firm reports its results tomorrow!
52-weeks Trading Range: $6.72 - $27.00
Entry Point: $24.70
Stop Loss: $23.20
Target Price: $27.10
MOMO closed at $20.00
Emerge Energy Services LP (EMES) acquires, owns, operates, and develops a portfolio of energy service assets in the United States.
The company operated in two segments, Sand and Fuel.
The Sand segment is involved in the production and sale of various grades of industrial sand primarily used in the extraction of oil and natural gas, as well as in the production of building products and foundry materials.
The Fuel segment operates two terminals and two transmix processing facilities located in the Dallas-Fort Worth, Texas area, as well as in Birmingham, Alabama. This segment also engages in the sale of wholesale petroleum products; provision of third-party terminaling services; blending of renewable fuels into petroleum products; manufacture of biodiesel; and provision of reclamation services, such as tank cleaning services, as well as other complementary products and services.
Emerge Energy Services GP, LLC operates as a general partner of the company.
Shares of this company have formed a bullish "cup and handle" after the firm sold its Fuel operations to Sunoco for $178.5 million on June 23rd. Once the transaction closes, it allows the firm to shore up its balance sheet and become a pure frac-sand play. We expect higher share prices for this stock. There is also a weak market rumor that the fuel business was sold so EMES can sell itself to a larger player!
52-Weeks Trading Range: $1.97 - $32.48
Entry Point: $11.40
Stop Loss: $10.80
Target Price: $12.54
EMES closed at $9.12.
Valeant Pharmaceuticals International, Inc. (VRX) develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide.
The company offers Solodyn to treat red and pus-filled pimples of acne in patients, as well as Ziana, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Wellbutrin XL for major depressive disorder in adults; Jublia for onychomycosis of the toenails; Xenazine for chorea; Targretin for Cutaneous T-Cell Lymphoma; Arestin, a subgingival sustained-release antibiotic; and PROVENGE for the treatment of prostate cancer. It also provides Zovirax, an antiviral for recurrent herpes labialis and initial genital herpes; Syprine to treat patients with Wilson's disease; Elidel to treat atopic dermatitis; Prolensa for inflammation and pain following cataract surgery; Duromine, a weight loss drug; and Lotemax gel for post-operative inflammation and pain.
In addition, the company offers PreserVision, an antioxidant eye vitamin and mineral supplement; CeraVe to rebuild and repair the skin barrier; ReNu Multiplus to lubricate and rewet soft contact lenses; Biotrue for healthy contact lens wear; Ocuvite, a lutein eye vitamin and mineral supplement; Boston, a cleansing solution for gas permeable contact lenses; Artelac to treat dry eyes; AntiGrippin for acute respiratory and respiratory viral diseases, and influenza; and Bedoyecta, a vitamin B complex product.
Further, it provides SofLens daily disposable contact lenses; PureVision, a contact lens; various ophthalmic surgical products; Biotrue ONEday lens; medical device systems for aesthetic applications; and Bausch + Lomb Ultra, a contact lens. Additionally, the company offers Tobramycin and Dexamethasone ophthalmic suspension for steroid responsive inflammatory ocular conditions; Cardizem CD to treat hypertension and angina; and Latanoprost for the treatment of glaucoma.
Shares of the beleagured pharmaceutial company have formed a "double bottom" following replacing the Company's CEO and an internal audit. This morning, the firm received a "new credit line from its banks', the news has shares higher in pre-market trading. We expect the recovery in shares to continue.
52-Weeks Trading Range: $25.27 - $263.81
Entry Point: $38.00
Stop Loss: $36.00
Target Price: $41.80
VRX closed at $25.00.
SolarCity Corporation (SCTY) designs, manufactures, installs, maintains, monitors, leases, and sells solar energy systems to residential, commercial, government, and other customers in the United States.
It offers solar energy systems; solar lease and power purchase agreement finance products; mounting hardware for photovoltaic panels; and related software, as well as develops a proprietary battery management system, which is designed to enable remote, bidirectional control of distributed energy storage that can provide benefits to customers, utilities, and grid operators.
The company also sells electricity generated by solar energy systems to customers. It offers its products and services through direct outside sales force; door-to-door sales force; call centers; channel partner network; and robust customer referral program.
This stock, along with others in the group, jumped last week after the Congress extended solar-subsidies for another five years. Most investors were not expecting this move by the Congress. Since then shares have formed a bullish "flag" formation. Higher share prices are expected for this stock.
Entry Point: $50.50
52-Weeks Trading Range: $24.07 - $63.79
Stop Loss: $48.00
Target Price: $55.60
SCTY closed at $34.30
IMAX Corporation (IMAX) operates as an entertainment technology company specializing in motion picture technologies and presentations worldwide.
The company operates in seven segments: IMAX Systems, Theater System Maintenance, Joint Revenue Sharing Arrangements, Film Production and IMAX Digital Re-Mastering (DMR), Film Distribution, Film Post-Production, and Other.
The IMAX Systems segment designs, manufactures, sells, or leases IMAX theater projection system equipment.
The Theater System Maintenance segment maintains IMAX theater projection system equipment in the IMAX theater network. The Joint Revenue Sharing Arrangements segment provides IMAX theater projection system equipment to exhibitors.
The Film Production and IMAX DMR segment produces films and performs film re-mastering services. The Film Distribution segment distributes films for which the company has distribution rights.
The Film Post-Production segment offers film post-production and film print services. The Other segment owns and operates IMAX theaters; rents two-dimensional and three-dimensional large-format film and digital cameras to third party production companies; and production technical support and post-production services.
The company also sells or leases its theater systems to theme parks, private home theaters, tourist destination sites, fairs, and expositions, as well as is involved in the after-market sale of projection system parts and 3D glasses. It primarily serves commercial multiplex exhibitors, as well as institutional customers, such as science and natural history museums, zoos, aquaria, and other educational and cultural centers.
Shares are expected head higher after a brief pullback Please see the 200-day moving average shown in green.
52-Weeks Trading Range: $28.60 - $43.80
Entry Point: $37.00
Stop Loss: $35.15
Target Price: $40.70
IMAX closed at $30.00
Cambrex Corporation (CBM) is a life sciences company.
The firm provides various products and services for the development and commercialization of new and generic therapeutics worldwide.
The companys products comprise active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products. It serves generic drug companies, and companies that discover and commercialize small molecule human therapeutics.
The company sells its products directly, as well as through independent agents.
This stock is a favorite of us and the shallow bullish "cup and handle" points to higher share prices.
52-Weeks Trading Range: $21.12 - $55.60
Entry Point: $51.25
Stop Loss: $48.65
Target Price: $56.38
CBM closed at $38.00
Fleetmatics Group PLC (FLTX) provides software-as-a-service fleet management solutions for small and medium-sized businesses (SMBs) worldwide.
The company offers Web-based and mobile application solutions that provide fleet operators with visibility into vehicle location, fuel usage, speed and mileage, and other insights into their mobile workforce. It provides Fleetmatics REVEAL, a business-intelligence based fleet management solution for SMBs; Fleetmatics REVEAL+, which extends Fleetmatics REVEAL to enterprises and is configurable to customers requiring integration capabilities with third-party workflow solutions; and Fleetmatics WORK, a field service management solution.
The company also offers Routist, an intelligent routing solution for businesses looking to optimize the utilization of their fleet and mobile resources; and Connect2Field, a cloud-based software solution for service businesses and their mobile workers.
It serves owners and managers in the service and distribution industries that operate fleets of commercial vehicles and manage a team of field technicians through direct sales organizations and Web.
Shares have formed a bullish "cup and handle" and higher share prices are expected for this stock.
52-Weeks Trading Range: $33.90 - $62.77
Entry Point: $60.90
Stop Loss: $57.85
Target Price: $67.00
FLTX closed at $42.10
Gray Television Inc. (GTN) is a broadcast company, which owns and/or operates television stations and digital assets in markets throughout the United States.
Gray owns and operates television stations in 44 television markets broadcasting 139 program streams including 76 affiliates of the Big Four networks (ABC, CBS, NBC and FOX). Gray's owned and/or operated stations include 26 channels affiliated with the CBS Network, 24 channels affiliated with the NBC Network, 16 channels affiliated with the ABC Network and 10 channels affiliated with the FOX Network.
Gray reaches approximately 8.1% of total United States television households.
Shares have formed a bullish "cup and handle" and higher share prices are expected for this stock.
52 Weeks Trading Range: $9.17 - $18.07
Entry Point: $17.05
Stop Loss: $16.15
Target Price: $18.76
GTN closed at $13.70
Callidus Software Inc. (CALD) provides enterprise software and related services to telecommunications, insurance, banking, and technology markets worldwide.
It offers Marketing Automation to generate sales leads by capturing intelligence about buyers' behaviors and engaging them across multiple channels; Territory and Quota to evaluate territory, quota distribution plans, and strategies for meeting corporate sales goals; Enablement that provides sales content at each step of the sales cycle; Litmos Learning Management System for training; Litmos Content to create courses that can be published to desktop browsers and mobile devices; and Sales Performance Manager to set targeted coaching plans to the individual sales professional.
The company also provides Configure-Price-Quote that guides sales representatives through the quoting process; Commissions that streamlines the design and management of incentive compensation programs and commission payments; Incentive Compensation Management that delivers automation in incentive and bonus plan configuration, plan payout, and producer management; Producer Management to manage producer hierarchies, licenses, appointments, education, correspondence, and book of business; and MySalesGame to drive performance-improving behavioral change.
In addition, it offers Surve that provides self-service tools to collect, centralize, and act on customer feedback; Thunderbridge Big Sales Data that combines big data technology with analytics and visualizations to enable real-time exploration of critical sales performance data; WorkFlow to optimize critical business processes and drive collaboration; and Data Hub that synchronizes sales opportunities, product catalogs, and human resource information across various applications, as well as provides professional, business process outsourcing, maintenance and technical support, and educational services.
Shares have formed a bullish "flag" following the company's latest quarterly resport. Its loss per share matched the estimates while sales topped the estimates. Callidus expects full-year earnings in the range of 18 cents to 21 cents per share, with revenue ranging from $172.3 million to $173.3 million. Higher share prices are expected for this stock.
52-Weeks Trading Range: $12.26 - $21.41
Entry Point: $21.00
Stop Loss: $19.80
Target Price: $23.05
CALD closed at $15.72
Total System Services, Inc. (TSS) provides electronic payment processing services to banks and other financial institutions in the United States, Europe, Canada, Mexico, and internationally.
It operates through four segments: North America Services, International Services, Merchant Services, and NetSpend.
The company offers account processing and output services, including processing the card application, initiating service for the cardholder, processing card transaction for the issuing retailer or financial institution, and accumulating the accounts transactions.
It also provides fraud management services to monitor the unauthorized use of accounts; fraud detection systems for identifying fraudulent transactions; and other services, such as customized communication services to cardholders, and information verification services associated with granting credit, debt collection, and customer service.
In addition, the company offers processing services, solutions, related systems, and integrated support services, which include processing various payment forms, such as credit, debit, prepaid, electronic benefit transfer, and electronic check; authorization and capture of transactions; clearing and settlement of transactions; information reporting services related to transactions; merchant billing services; and point-of-sale equipment sales and service.
Further, it provides general purpose reloadable prepaid debit cards and payroll cards, as well as alternative financial services to underbanked and other consumers; and transaction processing, disaster recovery, and other services for banks and bankcard issuers.
Shares have formed a bullish "cup and handle" and higher share prices are expected for this stock.
52-Weeks Trading Range: $32.06 - $55.00
Entry Point: $53.50
Stop Loss: $50.80
Target Price: $58.90
TSS closed at $41.00
Paycom Software, Inc. (PAYC) offers cloud-based human capital management (HCM) software solutions delivered as Softwareas-a-Service in the United States.
It provides functionality and data analytics that businesses need to manage the complete employment life cycle from recruitment to retirement.
Its HCM solution offers a suite of applications in the areas of talent acquisition including applicant tracking, candidate tracker, background checks, on-boarding, E-Verify, and tax credit service applications; time and labor management, such as time and attendance, scheduling/schedule exchange, time-off requests, labor allocation, and labor management reports/push reporting, payroll and tax management, Paycom Pay, expense management, and garnishment management applications.
The companys HCM solution also provides talent management applications comprising employee self-service, compensation budgeting, performance management, executive dashboard, and Paycom learning applications; and HR management applications, consisting of document and task management, government and compliance, benefits administration/benefits to carrier, COBRA administration, personnel action forms, surveys, and affordable care act dashboard applications. It primarily serves small to mid-sized companies.
Shares have formed a bullish "flag" following the company's recent earnings report. Higher share prices are expected for this stock.
NOTE: The company is selling 4.5M share Spot Secondary today priced at $42.15. We will use the weakness to establish a position.
52-Weeks Trading Range: $22.31 - $46.35
Entry Point: $42.15
Stop Loss: $40.00
Target Price: $46.40
PAYC closed at $30.00
Qualys, Inc. (QLYS) provides cloud security and compliance solutions in the United States and internationally.
The company offers QualysGuard cloud suite of solutions, such as Vulnerability Management, Policy Compliance, PCI Compliance, Web Application Scanning, Malware Detection Service, Web Application Firewall, and Qualys SECURE Seal. Its integrated suite of security and compliance solutions delivered on its QualysGuard Cloud Platform enables customers to identify their IT assets, collect and analyze large amounts of IT security data, discover and prioritize vulnerabilities, recommend remediation actions, and verify the implementation of such actions. It also provides QualysGuard core services, including asset tagging and management, reporting and dashboards, questionnaires and collaboration, remediation and workflow, big data correlation and analytics engine, and alerts and notifications, which enable integrated workflows, management and real-time analysis, and reporting across IT security and compliance solutions.
In addition, the company offers QualysGuard cloud infrastructure services that include the data, data processing capabilities, software and hardware infrastructure, and infrastructure management capabilities.
Qualys, Inc. markets and sells its IT security and compliance solutions to customers directly through its sales teams, as well as indirectly through its network of channel partners, such as security consulting organizations, managed service providers, and value added resellers. It serves enterprises, government entities, and small and medium-sized businesses in various industries, including education, financial services, government, healthcare, insurance, manufacturing, media, retail, technology, and utilities.
Shares have formed a bullish "cup and handle" ahead of its quarterly results on May 4th. We expect a strong report from the firm and higher share prices.
52-Weeks Trading Range: $18.00 - $54.78
Entry Point: $53.55
Stop Loss: $50.85
Target Price: $63.30
QLYS closed at $40.75 after it missed its quarterly results.
King Digital Entertainment plc (KING) is an interactive entertainment company.
The firm develops and publishes casual games on digital platforms. The Company makes casual games, which appeal to a wide and growing audience. Users access its games for free anywhere and anytime they wish to, either on their mobile devices, through social networks or via its Website, king.com.
The combination of wide game appeal, accessibility, and its multi-platform capabilities enables to attract a broad user base, foster viral growth, and create a compelling, fun and social experience.
The Company operates in developing and monetizing casual online and mobile games. As of December 31, 2013, the Company had a massive network of 324 million monthly users.
The company offers its games in a tournament format through its royalgames.com Website, as well as on mobile and social platforms, such as the Apple App Store, the Google Play Store, Facebook, the Amazon Appstore, and KakaoTalk.
Shares have formed a bullish "flag" when the "quiet period" following its recent IPO expired, and several brokerage houses upgraded the stock. Note that the formation is being supported by the stock's 50-day moving average (shown in red). Higher share prices are expected for this stock. Note that the firm reports its quarterly results this week.
52-Week Trading Range: $15.26 - $23.48
Entry Point: $19.10
Stop Loss: $18.14
Target Price: $21.01
KING fell below our stop loss. Closed at $14.